文献速递瓣膜病与结构性心脏病血脂与心血管预防

综合卒中中心认证与TAVR术后卒中报告率的关系及其对医院绩效评估的影响

The Association Between Hospital Comprehensive Stroke Center Designation Status and Stroke Rate Reporting in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry After Transcatheter Aortic Valve Replacement: Implications for Hospital Performance Assessment.
PubMed 文献 · Circulation · 2026-09-29

提示CSC认证可能与卒中报告率相关,公共报告需考虑 ascertainment bias。

要点

  • CSC认证与TAVR术后院内卒中和致残性卒中独立相关,但与对照终点无关。
  • 参与TAVR试验和术者手术量是30天卒中的独立预测因素。
  • 校正CSC状态后,153家CSC医院中8家30天复合模型绩效改善。

核心结论

  • CSC认证和参与TAVR试验是卒中特有的显著预测因素,校正CSC状态可影响部分医院在TVTR 30天复合模型中的绩效评估。

研究设计与样本

  • 基于STS/ACC TVT注册数据库的回顾性队列研究,纳入2016年1月至2023年6月连续TAVR病例,排除报告不足1年或总TAVR手术量<20例的中心。

主要发现

  • 多因素分析显示CSC状态和参与TAVR试验是院内卒中(P=0.033和0.012)及致残性卒中(P=0.033和0.007)的独立预测因素,但与 falsification 终点无关(P=NS)。
  • 参与TAVR试验和术者手术量是30天卒中的独立预测因素(P=0.039和P=0.041)。
  • 校正CSC状态后,153家CSC医院中8家30天复合模型绩效改善。

关键数值与推荐

  • CSC状态与院内卒中(P=0.033)和致残性卒中(P=0.033)独立相关;参与TAVR试验与院内卒中(P=0.012)和致残性卒中(P=0.007)独立相关。
  • 参与TAVR试验(P=0.039)和术者手术量(P=0.041)与30天卒中独立相关。
  • 校正CSC状态后,8/153家CSC医院30天复合模型绩效改善。

临床怎么用

  • 在解读TAVR术后卒中率及公共报告时,应考虑医院CSC认证状态和参与临床试验情况可能带来的报告偏倚。
  • 医院绩效评估模型可考虑纳入CSC状态等结构因素以校正 ascertainment bias。

局限性

  • 研究为观察性设计,可能存在未测量混杂和卒中 ascertainment bias。
  • 需进一步工作以在公共报告中处理卒中报告偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Michigan Structural Heart Consortium showed that transcatheter aortic valve replacement (TAVR) stroke rates were associated with hospital Comprehensive Stroke Center (CSC) designation, suggesting that hospital structural factors affect stroke reporting. We sought to determine whether CSC designation is nationally associated with reported stroke rates and the potential impact on hospital performance and Transcatheter Valve Therapy National Data Registry (TVTR) public reporting. METHODS: Consecutive TVTR cases from January 2016 through June 2023 were included, excluding sites reporting to the TVTR <1 year or performing <20 total TAVR procedures. The primary outcome was in-hospital stroke rate. Secondary outcomes were disabling stroke and 30-day stroke. Major bleeding, death, acute renal failure, and a composite end point were falsification end points to determine whether CSC status was uniquely associated with stroke. Multivariable hierarchical models were created starting with patient covariates and sequentially adding hospital variables to account for determinants of stroke. The impact of CSC status on hospital performance was estimated by correcting CSC hospital stroke rates in the validated TVTR 30-day composite model. RESULTS: A total of 525 919 TAVRs at 800 sites were included, and 10 963 strokes (2.1%) were reported within 30 days: 8284 (1.6%) in-hospital and 2679 (0.5%) after discharge. A total of 4733 (0.9%) were disabling strokes. Multivariate analysis showed that CSC status and participation in TAVR trials were independent predictors of in-hospital stroke rate (P=0.033 and 0.012) and disabling stroke (P=0.033 and 0.007), but not falsification end points (P=NS). Participation in TAVR trials and operator volume were independent predictors of 30-day stroke (P=0.039 and P=0.041). The impact of CSC status on the 30-day composite model showed performance improvement for 8 of 153 CSC hospitals. CONCLUSIONS: CSC hospital status and participation in TAVR trials are significant predictors unique for stroke. Correcting for the association of CSC status on stroke rate resulted in an estimated 8 of 153 hospitals improving their TVTR 30-day composite model performance. Further work is needed to account for potential ascertainment bias for stroke in public reporting.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Deeb GM, Grossman PM, Manandbar P, et al. The Association Between Hospital Comprehensive Stroke Center Designation Status and Stroke Rate Reporting in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry After Transcatheter Aortic Valve Replacement: Implications for Hospital Performance Assessment. Circulation. 2026. PMID: 42808167. doi:10.1161/CIRCULATIONAHA.125.078584

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。